Increased Number Of Cataract Patients In The U.S. To Boost The Intraocular Lens Market

A cataract is a medical condition in which the lens of the eye changes to become clouded. Increasing number of cataracts patients worldwide is one of the strongest reasons for the boost of the global Intraocular lens (IOL) market.

Increased instances of vision loss in individuals over 40 Years of age is the main reason for the blindness in the world. This has boosted the global IOL market. According to Prevent Blindness America (PBA), the number of cataracts cases in the world are more than glaucoma, macular degeneration, and diabetic retinopathy combined.

IOL is a lens that is implanted in the eye. It is mostly used as a part of cataracts or myopia treatment. The pseudophakic IOL is the most common type of IOL. These lenses are implanted when the natural lens of the cloudy eye is removed with the help of cataract surgery.

As stated by PBA, there are more than 22 Million Americans, with age group of 40 and above, affected by cataracts. Also, with the aging of the U.S. population, about more than 30 Million Americans may have cataracts by the year 2020. This condition of tremendous increase in the cataract patient will boost the IOL market in the U.S.

Rising technological advancements in this field and the implementation of these enhancements is also one of the reasons for the development of the global IOL market. Various companies such as LensGen are expanding their laboratories and research and development departments. This expansion is expected to boost the growth of the global IOL market.

Earlier, HOYA SURGICAL OPTICS announced that the company is launching a new global research and development center in Singapore. The research center was intended to focus on the global burden of cataract. The introduction of the latest R&D center will boost the growth of the IOL market in the Singapore area.